The activated YAP pathway decreased the susceptibility of cancer cells towards a variety of anti-cancer drugs, including RAF and MEK inhibitors28, anti-tubulin drugs41, 42, and DNA-damaging agents42, 43. This evidence concerns the gene MAP2K7 and cancer.